Sequential Monitoring of Clinical Trials: the Role of Information and Brownian Motion
Overview
Authors
Affiliations
Sequential monitoring has been a topic of major interest in clinical trials methodology over the past two decades. This paper presents a unified conceptual framework for sequential monitoring that covers a wide variety of monitoring procedures in a wide variety of clinical trial settings. The central elements of this framework consist of a suitable concept of statistical information and a scheme for using this concept as a basis for summarizing the accumulating results of a trial in a standardized form, through a stochastic process that can be shown to approximate classical Brownian motion. The ideas are developed in a simple step-by-step fashion and illustrated by several practical examples.
Sequential monitoring of cancer immunotherapy trial with random delayed treatment effect.
Wu J, Zhu L, Li Y J Biopharm Stat. 2023; 35(2):227-240.
PMID: 38146192 PMC: 11196386. DOI: 10.1080/10543406.2023.2296055.
Two Stage Designs for Phase III Clinical Trials.
Follmann D, Proschan M medRxiv. 2020; .
PMID: 32793927 PMC: 7418751. DOI: 10.1101/2020.07.29.20164525.
Group sequential design for historical control trials using error spending functions.
Wu J, Li Y J Biopharm Stat. 2019; 30(2):351-363.
PMID: 31718458 PMC: 7737423. DOI: 10.1080/10543406.2019.1684305.
Group Sequential Survival Trial Design and Monitoring Using the Log-Rank Test.
Wu J, Xiong X Stat Biopharm Res. 2017; 9(1):35-43.
PMID: 28966722 PMC: 5619877. DOI: 10.1080/19466315.2016.1189355.
Survival trial design and monitoring using historical controls.
Wu J, Xiong X Pharm Stat. 2016; 15(5):405-11.
PMID: 27307025 PMC: 5468795. DOI: 10.1002/pst.1756.